SEC Form 4 · accession 0001209191-16-114142
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Schimmel
Director
Period of report
Apr 12, 2016
Accepted (ET)
Apr 13, 2016 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 12, 2016 | P | 2,581 | $3.7512 | A | 20,412 | D | |
| Common StockF2,F3 | Apr 12, 2016 | P | 6,546 | $3.6999 | A | 240,127 | I | See Footnote |
| Common StockF4 | holding | — | — | — | 634,242 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.70 per share to $3.837 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- F2Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.69 per share to $3.70 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- F3These shares are owned directly by Paul R. Schimmel Prototype PSP. The Reporting Person is the trustee of the Paul R. Schimmel Prototype PSP.
- F4These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.